These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26368823)

  • 1. Epidemiology of invasive pneumococcal disease in Saudi Arabian children younger than 5years of age.
    Almazrou Y; Shibl AM; Alkhlaif R; Pirçon JY; Anis S; Kandeil W; Hausdorff WP
    J Epidemiol Glob Health; 2016 Jun; 6(2):95-104. PubMed ID: 26368823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
    Al-Mazrou KA; Shibl AM; Kandeil W; Pirçon JY; Marano C
    J Epidemiol Glob Health; 2014 Sep; 4(3):231-8. PubMed ID: 25107659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004).
    Shibl AM
    Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
    Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
    Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
    Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.
    Shibl A; Memish Z; Pelton S
    Int J Antimicrob Agents; 2009 May; 33(5):410.e1-9. PubMed ID: 18976887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines.
    Capeding MR; Bravo L; Santos J; Kilgore PE; Kim SA; Balter I; Hubler R; Ye J; Moscariello M
    Pediatr Infect Dis J; 2013 Oct; 32(10):e383-9. PubMed ID: 23629024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    Hjálmarsdóttir MÁ; Quirk SJ; Haraldsson G; Erlendsdóttir H; Haraldsson Á; Kristinsson KG
    PLoS One; 2017; 12(1):e0169210. PubMed ID: 28125588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation.
    dos Santos SR; Passadore LF; Takagi EH; Fujii CM; Yoshioka CR; Gilio AE; Martinez MB
    Vaccine; 2013 Dec; 31(51):6150-4. PubMed ID: 23747454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.